BioCryst Pharma (BCRX) PT Raised to $12 at Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Liisa Bayko raised the price target on BioCryst Pharma (NASDAQ: BCRX) to $12.00 (from $10.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
